Kylie A Abbott1, Tracy L Burrows2, Rohith N Thota1, Shamasunder Acharya3, Manohar L Garg4. 1. Schools of Biomedical Sciences and Pharmacy and. 2. Health Sciences, University of Newcastle, Callaghan, Australia; and. 3. Department of Endocrinology, John Hunter Hospital, Hunter New England Local Health District, Newcastle, Australia. 4. Schools of Biomedical Sciences and Pharmacy and manohar.garg@newcastle.edu.au.
Abstract
BACKGROUND: Evidence has suggested that omega-3 (n-3) polyunsaturated fatty acids (PUFAs) improve obesity-induced insulin resistance (IR); however, results from human intervention trials have been equivocal. Recently it has been reported that n-3 PUFA status is inversely associated with type 2 diabetes in women but not in men, suggesting a sex-dependent effect. OBJECTIVE: We aimed to determine whether n-3 PUFA interventions affect IR in a sex-dependent manner. DESIGN: Five databases were searched (Medline, EMBASE, CINAHL, Scopus, and Pre-Medline) for randomized controlled trials. Searches were limited to the English language and to studies with adults aged >18 y. When possible, studies were pooled for a meta-analysis. The principle summary measure was the standardized mean difference (SMD) between groups. RESULTS: Thirty-one eligible trials were identified with a total of 1848 participants [men: 45.1%; weighted mean ± SD age: 52.5 ± 8.2 y; weighted body mass index (in kg/m2): 28.8 ± 3.0]. Seven studies were conducted in women, 4 studies were conducted in men, and the remaining studies pooled men and women together. Twenty-six trials were pooled for the meta-analysis (men: n = 2; women: n = 6). With all studies (n = 26) pooled, there was no effect of n-3 PUFA on IR at the group level (SMD: 0.089; 95% CI: -0.105, 0.283; P = 0.367). In trials of ≥6 wk, a significant improvement in IR was seen in women (SMD: -0.266; 95% CI: -0.524, -0.007; P = 0.045) but not in men (SMD: 0.619; 95% CI: -0.583, 1.820; P = 0.313). CONCLUSIONS: With this analysis, we provide preliminary evidence of a sex-dependent response of IR to an n-3 PUFA intervention. Additional studies are needed to confirm sex-dependent associations and to elucidate the potential mechanisms that are involved. This trial was registered at www.crd.york.ac.uk/PROSPERO/ as CRD42015017940.
BACKGROUND: Evidence has suggested that omega-3 (n-3) polyunsaturated fatty acids (PUFAs) improve obesity-induced insulin resistance (IR); however, results from human intervention trials have been equivocal. Recently it has been reported that n-3 PUFA status is inversely associated with type 2 diabetes in women but not in men, suggesting a sex-dependent effect. OBJECTIVE: We aimed to determine whether n-3 PUFA interventions affect IR in a sex-dependent manner. DESIGN: Five databases were searched (Medline, EMBASE, CINAHL, Scopus, and Pre-Medline) for randomized controlled trials. Searches were limited to the English language and to studies with adults aged >18 y. When possible, studies were pooled for a meta-analysis. The principle summary measure was the standardized mean difference (SMD) between groups. RESULTS: Thirty-one eligible trials were identified with a total of 1848 participants [men: 45.1%; weighted mean ± SD age: 52.5 ± 8.2 y; weighted body mass index (in kg/m2): 28.8 ± 3.0]. Seven studies were conducted in women, 4 studies were conducted in men, and the remaining studies pooled men and women together. Twenty-six trials were pooled for the meta-analysis (men: n = 2; women: n = 6). With all studies (n = 26) pooled, there was no effect of n-3 PUFA on IR at the group level (SMD: 0.089; 95% CI: -0.105, 0.283; P = 0.367). In trials of ≥6 wk, a significant improvement in IR was seen in women (SMD: -0.266; 95% CI: -0.524, -0.007; P = 0.045) but not in men (SMD: 0.619; 95% CI: -0.583, 1.820; P = 0.313). CONCLUSIONS: With this analysis, we provide preliminary evidence of a sex-dependent response of IR to an n-3 PUFA intervention. Additional studies are needed to confirm sex-dependent associations and to elucidate the potential mechanisms that are involved. This trial was registered at www.crd.york.ac.uk/PROSPERO/ as CRD42015017940.
Authors: Ben van Ommen; Suzan Wopereis; Pepijn van Empelen; Hilde M van Keulen; Wilma Otten; Marise Kasteleyn; Johanna J W Molema; Iris M de Hoogh; Niels H Chavannes; Mattijs E Numans; Andrea W M Evers; Hanno Pijl Journal: Front Endocrinol (Lausanne) Date: 2018-01-22 Impact factor: 5.555
Authors: Jose Abuín-Fernández; María José Tapia-Guerrero; Rafael López-Urdiales; Sandra Herranz-Antolín; Jose Manuel García-Almeida; Katherine García-Malpartida; Mercedes Ferrer-Gómez; Emilia Cancer-Minchot; Luis Miguel Luengo-Pérez; Julia Álvarez-Hernández; Carmen Aragón Valera; Julia Ocón-Bretón; Álvaro García-Manzanares; Irene Bretón-Lesmes; Pilar Serrano-Aguayo; Natalia Pérez-Ferre; Juan José López-Gómez; Josefina Olivares-Alcolea; Carmen Arraiza-Irigoyen; Cristina Tejera-Pérez; Jorge Daniel Martínez-González; Ana Urioste-Fondo; Ángel Luis Abad-González; María José Molina-Puerta; Ana Zugasti-Murillo; Juan Parra-Barona; Irela López-Cobo; And Gabriel Olveira-Fuster Journal: Nutrients Date: 2020-05-27 Impact factor: 5.717
Authors: Rohith N Thota; Jessica I Rosato; Tracy L Burrows; Cintia B Dias; Kylie A Abbott; Ralph N Martins; Manohar L Garg Journal: Nutrients Date: 2020-05-30 Impact factor: 5.717